Management of Oral Ulcers

First-Line Management

The initial approach to oral ulcers should begin with topical treatments including steroids, barrier agents, and pain control measures, followed by systemic therapies for refractory cases based on the underlying cause and severity of the ulcers 1, 2, 3
Apply topical steroids as first-line therapy for oral ulcers, especially for accessible lesions 1, 2, 3
For localized ulcers, use clobetasol gel or ointment (0.05%) 1
For widespread or difficult-to-reach ulcers, use dexamethasone mouth rinse (0.1 mg/ml) 1
Consider betamethasone sodium phosphate 0.5 mg in 10 ml water as a rinse-and-spit preparation four times daily 4
Use topical anesthetic mouthwashes (viscous lidocaine 2%) before meals 2, 3
Apply benzydamine hydrochloride rinse or spray every 3 hours, particularly before eating 4
For severe pain, consider topical NSAIDs (e.g., amlexanox 5% oral paste) 2
Apply white soft paraffin ointment to lips every 2 hours 4
Use mucoprotectant mouthwashes (e.g., Gelclair) three times daily 4

Oral Hygiene and Supportive Care

Clean the mouth daily with warm saline mouthwashes 4
Use antiseptic oral rinses twice daily (e.g., 1.5% hydrogen peroxide or 0.2% chlorhexidine digluconate) 4
For dry mouth, recommend sugarless chewing gum, candy, or salivary substitutes 2

Second-Line Management for Refractory Cases

For ulcers that don't respond to topical therapy, consider intralesional steroid injections (triamcinolone weekly, total dose 28 mg) 1, 3
Consider systemic corticosteroids for highly symptomatic or recurrent ulcers (prednisone/prednisolone 30-60 mg or 1 mg/kg for 1 week with tapering over the second week) 1, 3
For recurrent aphthous stomatitis, try colchicine as first-line systemic therapy, especially for erythema nodosum or genital ulcers 5, 6
Consider azathioprine, interferon-alpha, TNF-alpha inhibitors, or apremilast in selected cases 6

Special Considerations

For ulcerated infantile hemangiomas, manage with barrier dressings, pain control (acetaminophen and cautious use of topical 2.5% lidocaine), and control of hemangioma growth 7, 8
Consider propranolol therapy for ulcerated hemangiomas 8
For Stevens-Johnson syndrome/toxic epidermal necrolysis with oral involvement, implement aggressive topical measures including steroids, anesthetics, and antiseptics 4
Consider systemic therapy for severe cases 4
For Behçet's syndrome, start with topical steroids and colchicine 5, 6, 9
Progress to immunosuppressives for refractory cases 6

Management of Oral Aphthous Ulcers

Common Pitfalls to Avoid

Premature tapering of corticosteroids before disease control is established is not recommended, as per the British Journal of Dermatology guidelines 10

Management of Oral Ulcers in Specific Conditions

Treatment Approaches

For recurrent aphthous stomatitis, colchicine can be considered as first-line systemic therapy, especially for erythema nodosum or genital ulcers, as recommended by the European League Against Rheumatism 11
The American Academy of Pediatrics suggests managing ulcerated infantile hemangiomas with barrier dressings, pain control, and control of hemangioma growth, and considering propranolol therapy 12
The International Journal of Oral Science recommends referring patients to a specialist for oral ulcers lasting more than 2 weeks or not responding to 1-2 weeks of treatment, with a strength of evidence level of moderate 13

Diagnostic Considerations

Blood tests, including full blood count, coagulation, fasting blood glucose level, HIV antibody, and syphilis serology examination, should be performed before biopsy to exclude contraindications and provide diagnostic clues, as suggested by the International Journal of Oral Science 13
Biopsy is indicated for ulcers lasting over 2 weeks or not responding to treatment, with a high level of evidence supporting this approach 13

Steroid Oral Paste for Aphthous Ulcers in Children

First-Line Topical Steroid Options

The British Journal of Dermatology recommends triamcinolone acetonide 0.1% paste applied directly to dried ulcer 2-4 times daily for localized lesions 14
The British Journal of Dermatology suggests clobetasol 0.05% ointment mixed in 50% Orabase applied twice weekly to dried mucosa for more severe localized ulcers 14
The British Journal of Dermatology advises betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water used as rinse-and-spit solution 2-4 times daily for multiple or widespread ulcers 14
Barrier preparations, such as Gelclair or Gengigel, can be applied three times daily for mucosal protection, as recommended by the British Journal of Dermatology 14

Second-Line Options for Refractory Cases

The British Journal of Dermatology recommends intralesional triamcinolone injections weekly for persistent ulcers 14
The Journal of Crohn's and Colitis and Gut suggest systemic corticosteroids, such as prednisone/prednisolone 1 mg/kg (maximum 40-60 mg) for 1 week with tapering over the second week, for highly symptomatic cases 15, 16
The British Journal of Dermatology advises tacrolimus 0.1% ointment applied twice daily for 4 weeks as an alternative to triamcinolone 14

Dosing Considerations for Children

The Journal of Crohn's and Colitis and Gut recommend pediatric dosing of systemic corticosteroids at 1-1.5 mg/kg/day up to a maximum of 60 mg for severe cases 15, 16

Treatment of Oral Ulcers in Special Populations

First-Line Topical Therapy for Oral Ulcers

The European League Against Rheumatism recommends topical corticosteroids as the cornerstone of initial management for oral ulcers, selected based on ulcer location and extent 17, 18

Third-Line Therapy for Recurrent Aphthous Stomatitis

The European League Against Rheumatism suggests colchicine as first-line systemic therapy for patients with recurrent ulcers (≥4 episodes per year), especially effective for erythema nodosum or genital ulcers 17, 18
Azathioprine, interferon-alpha, or TNF-alpha antagonists may be considered for resistant cases 17, 18

Special Considerations for Behçet's Disease

The European League Against Rheumatism recommends starting with topical corticosteroids for isolated oral ulcers in Behçet's syndrome 17, 18
Colchicine may be added for recurrent mucocutaneous involvement 17, 18, 19
Azathioprine, interferon-alpha, or TNF-alpha antagonists may be used for refractory cases 17, 18, 19
Sucralfate suspension has demonstrated efficacy in RCT for oral and genital ulcers 17, 18

Critical Pitfalls to Avoid

The American College of Rheumatology advises against tapering corticosteroids prematurely before disease control is established, and to avoid ciclosporine A in patients with neurological involvement due to neurotoxicity risk 17, 18, 19

Management of Traumatic Oral Ulcers in Elderly Denture Wearers

Initial Assessment and Denture Management

Remove ill‑fitting dentures immediately and postpone re‑wearing until the oral mucosa has fully healed to eliminate mechanical trauma【20】.
Have a dental professional inspect dentures for sharp edges, over‑extension, or unbalanced occlusion that could be causing ulceration【20】.
When temporary denture use is unavoidable, soak the denture for 10 minutes in a 0.2 % chlorhexidine antimicrobial solution before insertion【20】.

Epidemiology of Traumatic Ulcers

Traumatic ulcers related to denture wear occur in approximately 5 % of denture‑wearing individuals, typically appearing at sites that correspond to the shape of the offending denture surface【21】.

Red‑Flag Indicator and Referral

Any oral ulcer that persists for more than 2 weeks despite appropriate treatment should be biopsied to rule out squamous cell carcinoma, because chronic denture irritation can, albeit rarely, predispose to malignancy【21】.

Biopsy Indications and Timely Re‑evaluation for Persistent Tongue Ulcers

Indications for Biopsy

In patients with a tongue ulcer that does not resolve after 2 weeks of appropriate conservative treatment, a diagnostic biopsy should be performed to exclude malignancy or other serious pathology. 22

Importance of Early Re‑evaluation

Clinicians should re‑assess any tongue ulcer within 1–2 weeks; failure to show improvement warrants prompt investigation, as persistent lesions may indicate an underlying condition requiring further work‑up. 22

Management of Everolimus‑Induced Oral Ulcers – Evidence‑Based Recommendations

First‑Line Treatment Algorithm

Grade 1 Stomatitis (Erythema Only)

Continue everolimus at the current dose while providing symptomatic oral care 23.
Use 0.9 % saline or sodium bicarbonate rinses to soothe the oral mucosa 23.
Restrict mouthwashes to non‑alcoholic formulations 23.
Implement prophylaxis against fungal, viral, and bacterial infections 23.
Treat any secondary oral infections with appropriate topical or systemic antimicrobials 23.

Grade 2 Stomatitis (Patchy Ulcerations or Pseudomembranes)

Consider temporary interruption or dose reduction of everolimus if the ulceration is intolerable 23.

Grade 3 Stomatitis (Severe Ulceration)

Discontinue everolimus immediately 23.
Admit the patient for supportive care, including pain management and antimicrobial therapy 23.
After resolution to ≤ grade 1, restart everolimus at a lower dose 23.

Supportive Care – Dietary Modifications

Advise a diet of soft, moist, non‑irritating foods that are easy to chew and swallow 23.
Recommend avoidance of acidic, spicy, salty, or rough/coarse foods 23.
Serve foods at room temperature or chilled to reduce mucosal irritation 23.
Supplement meals with high‑calorie, high‑protein drinks to maintain nutrition 23.
Encourage adequate hydration by drinking plenty of water 23.
Use a lip balm or soft paraffin ointment to protect dry lips 23.

Critical Pitfalls to Avoid

Evaluate dental appliances (e.g., braces, dentures, retainers) before initiating everolimus, as they may exacerbate oral mucositis 23.
Maintain rigorous oral hygiene throughout therapy; consistent cleaning is essential for prevention of ulceration 23.